From: Cancer survivorship: understanding the patients’ journey and perspectives on post-treatment needs
Participant Characteristics | ||
---|---|---|
Variable | Overall (n = 29) | |
Demographic profile | Age (year, mean (SD)) | 52.9 (7.2) |
Gender (female, No. (%)) | 28 (96.6) | |
Time since diagnosis (years, mean (SD)) | 3.19 (2.6) | |
Cancer type (No. (%)) | Breast cancer | 22 (75.9) |
Multiple myeloma | 2 (6.9) | |
Prostate cancer | 1 (3.5) | |
Cervical cancer | 1 (3.5) | |
Brain cancer | 1 (3.5) | |
Kidney cancer | 1 (3.5) | |
Breast cancer, cervical cancer and Non-Hodgkin’s lymphoma | 1 (3.5) | |
Treatment type (No. (%)) | Surgery | 26 (89.7) |
Radiotherapy | 24 (82.7) | |
Chemotherapy | 23 (79.3) | |
Hormonal therapy | 15 (51.7) | |
Targeted therapy | 3 (10.3) | |
Stem cell transplant | 2 (6.9) | |
Immunotherapy | 1 (3.5) | |
Body Composition | BMI (Average, SD) Female | 30.1 (5.9) |
BMI (Male participant) | 28.1 | |
Physical activity levels | Moderately Active (No. (%)) | 35% |
Inactive (No. (%)) | 64% | |
(The Male participant was moderately active) |